SEMA7A, or CD108w, was first recognized for its expression on lymphocytes[50]; however, a role for SEMA7A in cancer was later identified through its association with Plexin-C1, the receptor for the viral homolog of SEMA7A. The gene discussed is PLXNC1; the disease is cancer.